Dear Duchenne Community, Earlier today we reported third quarter financial results and provided updates on Solid Biociences Inc.’ (“Solid”) business. Among the highlights, we shared new information about INSPIRE DUCHENNE, our clinical trial of our next-generation AAV gene therapy candidate, SGT-003, for the treatment of patients living with Duchenne. INSPIRE DUCHENNE: Status update INSPIRE DUCHENNE ... Read more
